• Home
  • Study Details
Coming Soon

IDH-Wildtype Glioblastoma Treatment Study

In this study, we will find out if a new experimental pill called ropidoxuridine can help improve the treatment of a brain cancer called IDH-Wildtype Glioblastoma. We want to see how well it works when used with radiation therapy.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study will start enrolling soon.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Soma Sengupta
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Brain and Other Nervous System)

IRB Number

24-1411

ClinicalTrials.gov

NCT06359379

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research